Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2

Journal of Clinical Investigation

Volumn 105, Issue 4, 2000, Pages 469-478

  Morteau, Olivier ^a,e   Morham, Scott G ^a,f   Sellon, Rance ^b,g   Dieleman, Levinus A ^a   Langenbach, Robert ^c   Smithies, Oliver ^a   Sartor, R Balfour ^a,d  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

^e HARVARD UNIVERSITY   (United States)

^f Utah   (United States)

^g WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; PROSTAGLANDIN E2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; COLON INJURY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ENZYME DEFICIENCY; MOUSE; MUCOSA INFLAMMATION; NONHUMAN; PRIORITY JOURNAL;

EID: 0033997088     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI6899     Document Type: Article

References (49)

1. Sartor, R.B., and Powell, D.W. 1991. In Diarrheal diseases. M. Field, editor. Elsevier Science. New York, NY. 75-114.
2. Sharon, P., Ligumsky, M., Rachmilewitz, D., and Zor, U. 1978. Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine. Gastroenterology. 75:638-640.
3. 2 before and after induction of colitis with trinitrobenzene sulfonic acid in rats decreases inflammation. Gastroenterology. 96:1290-1300.
4. Rachmilewitz, D., et al. 1989. Inflammatory mediators of experimental colitis in rats. Gastroenterology. 97:326-327.
5. Hoult, J.R.S., and Moore, P.K. 1978. Sulphasalazine is a potent inhibitor of prostaglandin 15 hydroxydehydrogenase: possible basis for therapeutic action in ulcerativc colitis. Br. J. Pharmacol. 64:6-8.
6. Knudsen, P.J., Dinarello, C.A., and Strom, T.B. 1986. Prostaglandin posttranscriptionally inhibit monocyte expression of interleukin 1 activity by increasing intracellular cyclic adenosine monophosphate. J. Immunol. 137:3189-3194.
7. Marcinkiewicz, J. 1991. In vitro cytokine release by activated murine peritoneal macrophages: role of prostaglandins in the differential regulation of tumor necrosis factor α, interleukin 1 and interleukin 6. Cytokine. 3:327-332.
8. Fedorak, R.N., Empey, L.R., MacArthur, C., and Jewell, L.D. 1990. Misoprostol provides a colonic mucosal protective effect during acetic acid-induced colitis in rats. Gastroenterology. 98:615-625.
9. Cohn, S.M., Schloemann, S., Tessner, T., Seibert, K., and Stenson, W.F. 1997. Crypt stem cell survival in the mouse intestinal epithelium is regulated by prostaglandins synthesis through cyclooxygenase-1. J. Clin. Invest. 99:1327-1379.
10. Yamada, T., et al. 1993. Mechanisms of acute and chronic intestinal inflammation induced by indomethacin. Inflammation. 17:641-662.
11. Kaufmann, H.J., and Taubin, H.L. 1987. Nonsteroidal anti-inflammatory drugs activate quiescent inflammatory bowel disease. Ann. Intern. Med. 107:513-516.
12. Bjarnason, I., Hayllar, J., MacPherson, A.J., and Russell, A.S. 1993. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology. 104:1832-1847.
13. Wallace, J.L., Keenan, C.M., Gale, D., and Shoupe, T.S. 1992. Exacerbation of experimental colitis by NSAIDs is not related to elevated leukotriene B4 synthesis. Gastroenterology. 102:18-27.
14. Olson, G.A., Leffler, C.W., and Fletcher, A.M. 1985. Gastroduodenal ulceration in rabbits producing antibodies to prostaglandins. Prostaglandins. 29:475-480.
15. 2. Gastroenterology. 93:744-752.
16. Masferrer, J.L., Isakson, P.C., and Seibert, K. 1996. Cyclooxygenase-2 inhibitors: a new class of anti-inflammatory agents that spare the gastrointestinal tract. Gastroenterol. Clin. North Am. 25:363-372.
17. Selbert, K., et al. 1994. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc. Natl. Acad. Sci. USA. 91:12013-12017.
18. O'Banion, M.K., Sadowski, H.B., Winn, V., and Young, D.A. 1991. A serum- and glucocorticoid-regulatecl 4 kilobase mRNA encodes a cyclooxygenase-related protein. J. Biol Chem. 266:23261-23267.
19. Tessner, T., Cohn, S., Schloemann, S., and Stenson, W.F. 1998. Prostaglandins prevent decreased epithelial cell proliferation associated with dextran sodium sulfate injury in mice. Gastroenterology. 115:874-882.
20. O'Banion, M.K., Miller, J.C., Chang, J.W., Kaplan, M.D., and Coleman, P.D. 1996, Interleukin I beta induces prostaglandin G/H synthase-2 (cyclooxygenase-2) in primary murine astrocyte culture. J. Neurochem. 66:2532-2540.
21. 2 production in resting macrophages. Biochem. Biopbys. Res. Commun. 136:94-101.
22. 2 and cAMP. J. Immunol. 141:587-591.
23. Jobin, C., Morteau, O., Han, D.S., and Sartor, R.B. 1998. Specific NF-kappa B blockade selectively inhibits tumour necrosis factor-alpha-induced COX-2 but not constitutive COX-1 gene expression in HT-29 cells. Immunology. 95:537-543.
24. Ethridge, R.T., Hellmich, M.R., DuBois, R.N., and Evers, B.M. 1998. Inhibition of heat-shock protein 70 induction in intestinal cells overexpressing cyclooxygenase 2. Gastroenterology. 115:1454-1463.
25. Xie, W., Robertson, D.L., and Simmons, D.L. 1992. Mitogen-inducible prostaglandin G/H synthase: a new target for nonsteroidal anti-inflammatory drugs. Drug Dev. Res. 25:249-265.
26. Chan, C.C., et al. 1995. Pharmacology of a selective cyclooxygenase-2 inhibitor, L-745,337: a novel nonsteroidal anti-inflammatory agent with an ulcerogenic sparing effect in rat and nonhuman primate stomach. J. Pharmacol. Exp. Ther. 274:1531-1537.
27. Masferrer, J.L., et al. 1994. Selective inhibition of inducible cyclooxygenase. Proc. Natl. Acad. Sci. USA. 91:3228-3232.
28. Laine, L., et al. 1999. A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2-specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis. Gastroenterology. 117:776-783.
29. Mizuno, H., et al. 1997. Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice. Gastroenterology. 112:645-648.
30. Reuter, B.K., Asfaha, S., Buret, A., Sharkey, K.A., and Wallace, J.L. 1996. Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2. J. Clin. Invest. 98:2076-2085.
31. Langenbach, R., et al. 1995. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell 83:483-492.
32. Morham, S.G., et al. 1995. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell. 83:473-482.
33. Cooper, H.S., Murthy, S.N.S., Shah, R.S., and Sedergran, D.J. 1993. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab. Invest. 69:238-249.
34. 2 cytokines. Clin. Exp. Immunol. 114:385-391.
35. Sellon, R.K., et al. 1998. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient. Infect. Immun. 66:5224-5231.
36. Axelsson, L.G., Landstrom, E., Bylund-Fellenius, A.C. 1998. Experimental colitis induced by dextran sulphate sodium in mice: beneficial effects of sulphasalazine and olsalazine. Aliment. Pharmacol. Ther. 12:925-934.
37. Stenson, W.F. 1997. Cyclooxygenase 2 and wound healing in the stomach. Gastroenterology. 112:645-648.
38. Wallace J.L., et al. 1998. Cyclooxygenase 1 contributes to inflammatory responses in rats and mice: implications for gastrointestinal toxicity. Gastroenterology. 115:101-109.
39. Kunkel, S.L., Chensue, S.W., Phan, S.H. 1986. Prostaglandins as endogenous mediators of interleukin-1 production. J. Immunol. 136:186-192.
40. Samali, A., and Cotter, T.G. 1996. Heat shock proteins increase resistance to apoptosis. Exp. Cell Res. 223:163-170.
41. Tsujii, M., and DuBois, R.N. 1995. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxidase synthase 2. Cell. 83:493-501.
42. Li, W.X., Chen, C.H., Ling, C.C., and Li, G.C. 1996. Apoptosis in heat-induced cell killing: the protective role of hsp-70 and the sensitization effect of the c-myc gene. Radiat. Res. 145:324-330.
43. Ferraz, J.G., et al. 1997. Induction of cyclooxygenase 1 and 2 in the rat stomach during endotoxemia: role in resistance to damage. Gastroenterology. 113:195-204.
44. Yeomans, N.D., Cook, G.A., and Giraud, A.S. 1998. Selective COX-2 inhibitors: are they safe for the stomach? Gastroenterology. 115:227-229.
45. Newberry, R.D., Stenson, W.F., Lorenz, R.G. 1999. Cyclooxygenase-2-dependent arachidonic acid metabolites are essential modulators of the intestinal immune response to dietary antigen. Nat. Med. 5:900-906.
46. Morteau, O. 1999. COX-2: promoting tolerance. Nat. Med. 5:867-868.
47. Mashimo, H., Wu, D.C., Podolsky, D.K., and Fishman, M.C. 1996. Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science. 274:262-265.
48. Kirtikara, K., et al. 1998. Compensatory prostaglandin E2 biosynthesis in cyclooxygenase 1 or 2 null cells. J. Exp. Med. 187:517-523.
49. Gilroy, D.W., et al. 1999, Inducible cyclooxygenase may have anti-inflammatory properties. Nat. Med. 5:698-701.